ENZO BIOCHEM INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Enzo Biochem Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Enzo Biochem Inc Return On Equity for the quarter ending October 31, 2024 was -37.5 %, a 179% decline year-over-year.
  • Enzo Biochem Inc annual Return On Equity for 2024 was -38.6 %, a 183% decline from 2023.
  • Enzo Biochem Inc annual Return On Equity for 2023 was 46.3 %.
  • Enzo Biochem Inc annual Return On Equity for 2022 was -29.4 %, a 337% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -37.5 -85.1 -179% Aug 1, 2024 Oct 31, 2024
Q2 2024 -38.6 -84.9 -183% May 1, 2024 Jul 31, 2024
Q1 2024 61.2 +182 Feb 1, 2024 Apr 30, 2024
Q4 2023 53.7 +126 Nov 1, 2023 Jan 31, 2024
Q3 2023 47.6 +94.4 Aug 1, 2023 Oct 31, 2023
Q2 2023 46.3 +75.7 May 1, 2023 Jul 31, 2023
Q1 2023 -121 -111 -1107% Feb 1, 2023 Apr 30, 2023
Q4 2022 -72.5 -72.9 -16134% Nov 1, 2022 Jan 31, 2023
Q3 2022 -46.9 -54.9 -684% Aug 1, 2022 Oct 31, 2022
Q2 2022 -29.4 -41.8 -337% May 1, 2022 Jul 31, 2022
Q1 2022 -9.99 -12.1 -576% Feb 1, 2022 Apr 30, 2022
Q4 2021 0.45 +18 Nov 1, 2021 Jan 31, 2022
Q3 2021 8.02 +40.9 Aug 1, 2021 Oct 31, 2021
Q2 2021 12.4 +54.7 May 1, 2021 Jul 31, 2021
Q1 2021 2.1 +43.3 Feb 1, 2021 Apr 30, 2021
Q4 2020 -17.6 -19.5 -1031% Nov 1, 2020 Jan 31, 2021
Q3 2020 -32.9 -33.9 -3341% Aug 1, 2020 Oct 31, 2020
Q2 2020 -42.3 -45.4 -1461% May 1, 2020 Jul 31, 2020
Q1 2020 -41.2 -43.9 -1630% Feb 1, 2020 Apr 30, 2020
Q4 2019 1.89 +31.7 Nov 1, 2019 Jan 31, 2020
Q3 2019 1.01 +19.9 Aug 1, 2019 Oct 31, 2019
Q2 2019 3.11 +15.1 May 1, 2019 Jul 31, 2019
Q1 2019 2.69 +7.76 Feb 1, 2019 Apr 30, 2019
Q4 2018 -29.8 -28.1 -1641% Nov 1, 2018 Jan 31, 2019
Q3 2018 -18.9 -17 -903% Aug 1, 2018 Oct 31, 2018
Q2 2018 -12 -9.14 -323% May 1, 2018 Jul 31, 2018
Q1 2018 -5.07 -42.9 -113% Feb 1, 2018 Apr 30, 2018
Q4 2017 -1.71 -41.2 -104% Nov 1, 2017 Jan 31, 2018
Q3 2017 -1.89 -57.1 -103% Aug 1, 2017 Oct 31, 2017
Q2 2017 -2.83 -77 -104% May 1, 2017 Jul 31, 2017
Q1 2017 37.9 +2.18 +6.11% Feb 1, 2017 Apr 30, 2017
Q4 2016 39.5 +1.84 +4.88% Nov 1, 2016 Jan 31, 2017
Q3 2016 55.2 +40.4 +273% Aug 1, 2016 Oct 31, 2016
Q2 2016 74.2 +80.4 May 1, 2016 Jul 31, 2016
Q1 2016 35.7 +74.8 Feb 1, 2016 Apr 30, 2016
Q4 2015 37.7 +69.1 Nov 1, 2015 Jan 31, 2016
Q3 2015 14.8 +45.3 Aug 1, 2015 Oct 31, 2015
Q2 2015 -6.19 +22.3 +78.2% May 1, 2015 Jul 31, 2015
Q1 2015 -39.2 -10.3 -35.6% Feb 1, 2015 Apr 30, 2015
Q4 2014 -31.4 +13.8 +30.5% Nov 1, 2014 Jan 31, 2015
Q3 2014 -30.5 +18 +37.1% Aug 1, 2014 Oct 31, 2014
Q2 2014 -28.5 +18.4 +39.3% May 1, 2014 Jul 31, 2014
Q1 2014 -28.9 +70.3 +70.9% Feb 1, 2014 Apr 30, 2014
Q4 2013 -45.2 +30.3 +40.2% Nov 1, 2013 Jan 31, 2014
Q3 2013 -48.5 +13 +21.2% Aug 1, 2013 Oct 31, 2013
Q2 2013 -46.9 +7.68 +14.1% May 1, 2013 Jul 31, 2013
Q1 2013 -99.2 -79.5 -403% Feb 1, 2013 Apr 30, 2013
Q4 2012 -75.5 Nov 1, 2012 Jan 31, 2013
Q3 2012 -61.5 Aug 1, 2012 Oct 31, 2012
Q2 2012 -54.6 May 1, 2012 Jul 31, 2012
Q1 2012 -19.7 Feb 1, 2012 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.